Pitavastatin Offers Therapeutic Potential in Cancers Arising From Chronic Inflammation
The statin pitavastatin (Livalo) could potentially inhibit the production of IL-33, which often contributes to the development of cancer via chronic inflammation, according to findings published in Nature Communications. “Fifteen to 20% of cancer deaths …